Analysis of AML patient serum revealed 2HG levels correlate with IDH mutational status and suggest a potential role as a prognostic, predictive and therapeutic-monitoring biomarker in AML [32,33]. The gene discussed is IDH1; the disease is acute myeloid leukemia.